Cargando…
Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible?
Autores principales: | Stefanopoulos, Anastasios, Economopoulos, Konstantinos P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101296/ http://dx.doi.org/10.1186/1617-9625-12-S1-A6 |
Ejemplares similares
-
Plasma nuclear matrix protein (NMP) levels in patients with multiple organ failure
por: Endo, S, et al.
Publicado: (1997) -
Zebrafish as model organism for cNMP research
por: Dittmar, Fanni, et al.
Publicado: (2015) -
Usefulness of the NMP22BladderChek Test for Screening and Follow-up of Bladder Cancer
por: Choi, Hwa Sub, et al.
Publicado: (2010) -
Comparison of urinary telomerase, CD44, and NMP22 assays for detection of bladder squamous cell carcinoma
por: Al-Delaimy, Wael K., et al.
Publicado: (2022) -
Comparison of the diagnostic performance of fluorescence in situ hybridization (FISH), nuclear matrix protein 22 (NMP22), and their combination model in bladder carcinoma detection: a systematic review and meta-analysis
por: Liang, Qindong, et al.
Publicado: (2018)